Navigation Links
HistoRx Licenses Melanoma Assay from Yale University
Date:12/21/2011

BRANFORD, Conn., Dec. 21, 2011 /PRNewswire/ -- HistoRx recently licensed from Yale University a new clinical diagnostic assay based on AQUA® technology.  This assay enables doctors treating patients with melanoma to identify a subset of those patients who, despite having no detectable cancer in their lymph nodes, have a 40% risk of recurrence of their disease.  AQUA technology is an automated, quantitative IHC testing method that enables measurement of protein biomarkers in tissue as an aid to a pathologist's diagnosis.  Such precise determination of first, the location within the tumor cell and second, the amount in each location is not possible with conventional testing methods, such as standard immunohistochemistry (IHC). 

The prognostic assay was developed in the laboratory of David Rimm, MD, PhD, inventor of AQUA technology and Professor of Pathology, Director of Pathology Tissue Services at the Yale School of Medicine, and may be useful in guiding treatment decisions for Stage II, node-negative melanoma patients.  "After surgical resection of the tumor, if the nodes are negative, we don't have much more to offer," said Dr. Rimm.  "This assay allows us to measure the risk of recurrence which can be helpful to ease patient anxiety or to prompt patients to be aggressive in follow up or even consider adjuvant chemotherapy."  

There are five biomarkers analyzed in the assay, and the amounts of each were measured in total and in the separate compartments of nucleus and cytoplasm.  Results are interpreted to delineate clearly between low-risk and high-risk patients; Dr. Rimm intentionally avoided creating an intermediate category which is not helpful to physician decision making.  The study is described in Dr. Rimm's 2009 article in the Journal of Clinical Oncology (v. 27, n. 34, pp. 5772 – 5780) which concludes that the assay is 'an independent determinant of melanoma surviva
'/>"/>

SOURCE HistoRx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Metamark and HistoRx Announce Licensing Agreement for AQUA® Technology
2. Jack Davis, Diagnostics Industry Executive, Joins the HistoRx Board of Directors
3. Heiner Dreismann, Ph.D., Former President of Roche Molecular Systems, Joins the HistoRx Board of Directors
4. HistoRx Receives Key Patent on Application of AQUA(R) Technology to Personalized Medicine
5. Genoptix and HistoRx Announce Licensing Agreement for AQUA(R) Technology
6. HistoRx Names Dick Carroll, Ph.D. as VP of Clinical Research
7. Roche Licenses Nanopore Sequencing Technologies from Arizona State University and Columbia University for Rapid, Affordable DNA Sequencing
8. CMC Biologics Licenses Its CHEF1® Expression System to Oxford BioTherapeutics
9. Eppendorf Licenses Technology for Thermal Cyclers to Bulldog Bio
10. Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health
11. EdeniQ Licenses Yeast Technology from USDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 Deep Research Report on ... in-depth research report on the Ammonium Bifluoride market, ... classification, application, and industry chain structure as well ... market analysis, including China’s domestic market as well ... China, Japan etc. regions) industry analysis covering macroeconomic ...
(Date:11/26/2014)... 26, 2014 In keeping with the ... a bevy of last-minute Thanksgiving savings. The company is ... across all product lines this holiday weekend as well ... Black Friday, and Cyber Monday are right around the ... to both loyal customers and those looking to explore ...
(Date:11/26/2014)... and PHILADELPHIA , Nov. 26, 2014 ... and unforgiving environments. Human exploration of space requires astronauts ... ensure mission safety and success, and prevent potential errors ... mission success, little is known about how cognition is ... are primarily affected. Now, Penn Medicine researchers ...
(Date:11/26/2014)... November 26, 2014 On January, 14, ... Baltimore and Washington D.C. science community to the UMBC ... event, sponsored by the Protein Society, will take place ... Center, Room 312. Through discussion, presentations and workshops, ... importance of proteins, their role in the industry and ...
Breaking Biology Technology:Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 2Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 3DNA Spectrum Offers Last Minute Thanksgiving Coupons 2DNA Spectrum Offers Last Minute Thanksgiving Coupons 3Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 2Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 3Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 4
... Business and technology opportunities are affording today,s ... decades ago—the chance to create successful new companies ... leaders who will speak at Keck Graduate Institute ... of KGI,s Focus Track Fridays seminar series, executives ...
... Pharmasset, Inc. (Nasdaq: VRUS ), a ... commercializing novel drugs to treat viral infections, today reported ... ended September 30, 2011. At fiscal year end Pharmasset ... used $21.7 million of our cash and cash equivalents ...
... inVentiv Health, Inc., offering best-in-class clinical, commercial ... today that it has been selected by the ... operations support, as well as recruiting and sales ... for Type 2 diabetes. inVentiv ...
Cached Biology Technology:'Garage' Start-ups Now Possible in Life Sciences Industry 2Pharmasset Reports Fiscal Year End 2011 Financial Results 2Pharmasset Reports Fiscal Year End 2011 Financial Results 3Pharmasset Reports Fiscal Year End 2011 Financial Results 4Pharmasset Reports Fiscal Year End 2011 Financial Results 5Pharmasset Reports Fiscal Year End 2011 Financial Results 6Pharmasset Reports Fiscal Year End 2011 Financial Results 7Pharmasset Reports Fiscal Year End 2011 Financial Results 8inVentiv Health Selected to Provide Sales Operations Support for Santarus 2inVentiv Health Selected to Provide Sales Operations Support for Santarus 3inVentiv Health Selected to Provide Sales Operations Support for Santarus 4
(Date:11/5/2014)... professor of biology in the UTSA College of ... nation selected to receive a two-year $300,00 National ... Research (EAGER). The funding supports President Obama,s BRAIN ... create new technology that will demystify complex brain ... in neuroscience are broken into the interactions of ...
(Date:11/4/2014)... right amount of death at the right time might ... new research that could help in understanding animal populations, ... In a paper in the journal Trends in ... European colleagues conclude that the kind of positive population ... individuals, or mortality, depends on the size and developmental ...
(Date:11/4/2014)... England , November 4, 2014 ... and vertical market growth   Fuel3D , ... has closed a funding round totaling $6.4 million (£4 million). ... million) funding secured earlier this year and paves the way ... in 2015. The funding round was led by ...
Breaking Biology News(10 mins):UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3When less is more: Death in moderation boosts population density in nature 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3
... such as Alzheimer,s disease, Parkinson,s disease, and amyotrophic ... for patients, put a tremendous burden on family ... The most consistent risk factor for developing ... increase in life expectancy, the incidence of individuals ...
... 2008 On the day Americans elect a new president, ... at the University of Houston and outline the daunting global ... Trenberth, head of climate analysis at the National Center for ... manmade global warming at a colloquium Tuesday, Nov. 4. ...
... Although research has linked inbreeding with elevated rates of ... study finds it plays no part in the high ... recently examined 2,000 adult and juvenile salamanders and found ... missing, extra or dwarfed digits (equivalent to fingers and ...
Cached Biology News:3-substituted indolones as novel therapeutic compounds for neurodegenerative conditions 2Climate change expert to discuss grim global warming predictions 2Study rules out inbreeding as cause of amphibian deformities 2
... state-of-the-art separation system using the asymmetric flow ... integrates easily with Wyatts multi-angle light scattering ... as the Optilab DSP. The combined system ... of the particles/molecules separated by the AFFF ...
Monoclonal antibodies conjugated with rhodamine...
... Both compact and lightweight, the Moticam ... microscope through the eyepiece, eyetube, or trinocular ... easy to use Plug-and-Play Images 2.0ML software ... Image manipulation tools to maximize resolution for ...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
Biology Products: